Saurabh Saha Centessa Pharmaceuticals PLC (CNTA) insider trading activity

CNTA Quotes by TradingView

Saurabh Saha is Chief Executive Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 221,017 shares of CNTA, which is worth approximately $3.78 Million. The most recent transaction as insider was on Jul 21, 2025, when has been sold 55,000 shares (Ordinary Shares) at a price of $15.92 per share, resulting in proceeds of $875,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0% 3M change
73.43% 12M change
Total Value Held $3.78 Million

SAURABH SAHA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2025
SELL
Open market or private sale
$875,600 $15.92 p/Share
55,000 Reduced 19.93%
221,017 Ordinary Shares
Jul 21 2025
BUY
Exercise of conversion of derivative security
$211,750 $3.85 p/Share
55,000 Added 16.62%
276,017 Ordinary Shares
Jun 20 2025
SELL
Open market or private sale
$694,650 $12.63 p/Share
55,000 Reduced 19.93%
221,017 Ordinary Shares
Jun 20 2025
BUY
Exercise of conversion of derivative security
$211,750 $3.85 p/Share
55,000 Added 16.62%
276,017 Ordinary Shares
May 20 2025
SELL
Open market or private sale
$699,050 $12.71 p/Share
55,000 Reduced 19.93%
221,017 Ordinary Shares
May 20 2025
BUY
Exercise of conversion of derivative security
$211,750 $3.85 p/Share
55,000 Added 16.62%
276,017 Ordinary Shares
Apr 22 2025
SELL
Open market or private sale
$501,475 $12.43 p/Share
40,344 Reduced 15.44%
221,017 Ordinary Shares
Apr 21 2025
SELL
Open market or private sale
$180,122 $12.29 p/Share
14,656 Reduced 5.31%
261,361 Ordinary Shares
Mar 20 2025
SELL
Open market or private sale
$917,950 $16.69 p/Share
55,000 Reduced 16.62%
276,017 Ordinary Shares
Feb 20 2025
SELL
Open market or private sale
$892,650 $16.23 p/Share
55,000 Reduced 14.25%
331,017 Ordinary Shares
Feb 01 2025
SELL
Payment of exercise price or tax liability
$734,006 $16.92 p/Share
43,381 Reduced 10.1%
386,017 Ordinary Shares
Jan 21 2025
SELL
Open market or private sale
$878,900 $15.98 p/Share
55,000 Reduced 11.35%
429,398 Ordinary Shares
Dec 31 2024
SELL
Payment of exercise price or tax liability
$592,900 $16.35 p/Share
36,263 Reduced 6.96%
484,398 Ordinary Shares
Dec 20 2024
SELL
Open market or private sale
$959,200 $17.44 p/Share
55,000 Reduced 9.55%
520,661 Ordinary Shares
Dec 06 2024
SELL
Open market or private sale
$1,615,176 $18.46 p/Share
87,496 Reduced 13.19%
575,661 Ordinary Shares
Dec 06 2024
BUY
Exercise of conversion of derivative security
$510,976 $5.84 p/Share
87,496 Added 11.66%
663,157 Ordinary Shares
Nov 25 2024
SELL
Open market or private sale
$5,450 $18.23 p/Share
299 Reduced 0.05%
575,661 Ordinary Shares
Nov 25 2024
BUY
Exercise of conversion of derivative security
$1,746 $5.84 p/Share
299 Added 0.05%
575,960 Ordinary Shares
Nov 22 2024
SELL
Open market or private sale
$30,479 $18.24 p/Share
1,671 Reduced 0.29%
575,661 Ordinary Shares
Nov 22 2024
BUY
Exercise of conversion of derivative security
$9,758 $5.84 p/Share
1,671 Added 0.29%
577,332 Ordinary Shares
Nov 21 2024
SELL
Open market or private sale
$64,040 $18.24 p/Share
3,511 Reduced 0.61%
575,661 Ordinary Shares
Nov 21 2024
BUY
Exercise of conversion of derivative security
$20,504 $5.84 p/Share
3,511 Added 0.6%
579,172 Ordinary Shares
Nov 20 2024
SELL
Open market or private sale
$928,950 $16.89 p/Share
55,000 Reduced 8.72%
575,661 Ordinary Shares
Nov 13 2024
SELL
Open market or private sale
$585,380 $18.28 p/Share
32,023 Reduced 4.83%
630,661 Ordinary Shares
Nov 13 2024
BUY
Exercise of conversion of derivative security
$187,014 $5.84 p/Share
32,023 Added 4.61%
662,684 Ordinary Shares

Also insider at

CLVT
CLARIVATE Plc Technology
Director
SS

Saurabh Saha

Chief Executive Officer
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNTA